Get started
Author

Vasileios‐Periklis Stamatellos

Observed names: Vasileios Periklis Stamatellos, Vasileios-Periklis Stamatellos, Vasilieios‐Periklis Stamatellos
Institution: DRK Kliniken Berlin
ORCID: 0000-0002-5063-2300
Observed ORCID: 0000-0002-5063-2300
OpenAlex ID: A5086205105
S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal
2022 · Vasileios-Periklis Stamatellos, Antigony Rigas, et al. · Multiple Sclerosis and Related Disorders · 28
Disease‐modifying agents for multiple sclerosis and the risk for reporting cancer: A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database
2021 · Vasileios‐Periklis Stamatellos, Spyridon Siafis, et al. · British Journal of Clinical Pharmacology · 25
Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects
2022 · Εleni Stamoula, Alexandra Ainatzoglou, et al. · Multiple Sclerosis and Related Disorders · 24
Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
2022 · Georgios Papazisis, Vasileios-Periklis Stamatellos · Current Clinical Pharmacology · 19
The role of neuroinflammation in schizophrenia: Focus on Th17 cells functions
2025 · Mikhail Melnikov, Anna Lopatina, et al. · Asian Journal of Psychiatry · 8
Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)
2023 · Eleni Stamoula, Vasileios-Periklis Stamatellos, et al. · Expert Opinion on Drug Safety · 5
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models
2022 · Еleni Stamoula, Alexandra Ainatzoglou, et al. · CNS & Neurological Disorders - Drug Targets · 5
Demyelinating Sarcoid Polyneuropathy With Reversible Conduction Block: A Case‐Report
2025 · Stanislav Svergun, Vasilieios‐Periklis Stamatellos, et al. · Neurology and Clinical Neuroscience
PDF
Commentary: Coexistence of anti-NMDA receptor (NMDAR) encephalitis and MOGAD
2025 · Vasileios-Periklis Stamatellos · Journal of Clinical Neuroscience
Neuroborreliosis in a patient with Multiple Sclerosis on Ocrelizumab, a case report
2023 · Vasileios Periklis Stamatellos, Gunnar Ulm, et al. · Research Square
PDF
Works count: 10
Citation count: 114
H-index: 5
I10-index: 4
Year
Topic
Type